Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA

Wilson, D. et al. (2019) Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA. BMJ Open, 9(7), e028387. (doi: 10.1136/bmjopen-2018-028387) (PMID:31345970) (PMCID:PMC6661679)

[img]
Preview
Text
191023.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.

322kB

Abstract

Objective We report on: (1) the proportion of patients with known atrial fibrillation (AF); and (2) demographic, clinical or radiological differences between patients with known AF (and not treated) and patients with newly diagnosed AF, in a cohort of patients who presented with ischaemic stroke or transient ischaemic attack (TIA) not previously treated with anticoagulation. Design We reviewed cross-sectional baseline demographic and clinical data from a prospective observational cohort study, (CROMIS-2). Setting Patients were recruited from 79 hospital stroke centres throughout the UK and one centre in the Netherlands. Participants Patients were eligible if they were adults who presented with ischaemic stroke or TIA and AF and had not been previously treated with oral anticoagulation. Main outcome measures Proportion of patients with known AF before index ischaemic stroke or TIA from a cohort of patients who have not been previously treated with oral anticoagulation. Secondary analysis includes the comparison of CHA2DS2-VASc and HAS-BLED scores and other demographics and risk factors between those with newly diagnosed AF and those with previously known AF. Results Of 1470 patients included in the analysis (mean age 76 years (SD 10)), 622 (42%) were female; 999 (68%) patients had newly diagnosed AF and 471 (32%) patients had known AF. Of the 471 patients with known AF, 68% had a strong indication for anticoagulation and 89% should have been considered for anticoagulation based upon CHA2DS2-VASc score. Patients with known AF were more likely to have a prior history of dementia (4% vs 2%, p=0.02) and had higher HAS-BLED scores (median 3 vs 2). CHA2DS2-VASc, other risk factors and demographics were similar. Conclusions About 1/3 of patients who present with stroke and have AF who have not been treated with oral anticoagulation have previously known AF. Of these patients, at least 68% were not adequately treated with oral anticoagulation. Trial registration number NCT02513316.

Item Type:Articles
Additional Information:CROMIS-2 is funded by the Stroke Association and British Heart Foundation and this study was funded by University College London.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Muir, Professor Keith
Authors: Wilson, D., Ambler, G., Shakeshaft, C., Banerjee, G., Charidimou, A., Seiffge, D., White, M., Cohen, H., Yousry, T., Salman, R., Lip, G. Y.H., Muir, K., Brown, M. M., Jäger, H.R., and Werring, D. J.
College/School:College of Medical Veterinary and Life Sciences > Institute of Neuroscience and Psychology
Journal Name:BMJ Open
Publisher:BMJ Publishing Group
ISSN:2044-6055
ISSN (Online):2044-6055
Copyright Holders:Copyright © 2019 The Authors
First Published:First published in BMJ Open 9(7):e028387
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record